These patient-centered recommendations emphasize the importance of team-based care delivery, shared decision-making, and the evaluation of social determi- nants of health in ASCVD prevention efforts. These rec- ommendations apply to all aspects of clinical practice for the primary prevention of ASCVD. Recommendation-Specific Supportive Text 1. Team-based care makes use of multidisciplinary health professionals to improve the quality and maintenance of ASCVD prevention. It is a multi- faceted approach that supports clinical decision- making (ie, treatment algorithms), collaboration among different clinicians, and patient and fam- ily member participation to facilitate the treat- ment goals of patients.S2.1-26 RCTs and systematic reviews with meta-analyses demonstrated greater reduction of ASCVD risk with team-based care than with usual care in patients with hyperten- sion, diabetes, and hyperlipidemia.S2.1-1 S2.1-14 A team-based approach to ASCVD prevention may result in significant improvements in patient out- and often meets patient needs bet- ter than standard care, especially in low-resource settings and among vulnerable populations. In a team-based care model that compared patients enrolled in a preventive cardiology clinic staffed by advanced practice providers with a propensity- matched cohort of patients enrolled in primary care clinics, a reduction in cardiovascular risk was demonstrated through effective risk stratification and preventive management.S2.1-28 Other success- ful interventions that have used team-based care include telehealth monitoring, follow-up support aids, and patient education.S2.1-27 2. Decisions about primary prevention should be collaborative between a clinician and a patient. Shared decision-making occurs when practitioners engage patients in discussions about personal- ized ASCVD risk estimates and their implications for the perceived benefits of preventive strate- gies, including lifestyle habits, goals, and medical therapies. Collaborative decisions are more likely to address potential barriers to treatment options, compared with treatment and guidance offered without patient input.S2.1-15 S2.1-18 3. 